Mometasone

Mometasone

Drug monograph · NCLEX study reference
Trade names	Asmanex
Therapeutic class	Anti-inflammatory (respiratory)
Pharmacologic class	Inhaled corticosteroid
Onset / peak / duration	Builds over days to weeks.
Half-life / level	Local action.
Routes	Inhaled
High-alert (ISMP)	No
Black box warning	None
Antidote / reversal	Not applicable.
Pregnancy / lactation	Use if needed.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Mometasone (brand name Asmanex) — Anti-inflammatory (respiratory); Inhaled corticosteroid.

Identification

• Therapeutic class: Anti-inflammatory (respiratory).
• Pharmacologic class: Inhaled corticosteroid.

Pharmacology

• Mechanism of action: Reduces airway inflammation.
• Onset / peak / duration: Builds over days to weeks.
• Half-life / therapeutic level: Local action.

Clinical use

• Indications: Asthma maintenance.
• Usual dose, route, frequency: Inhaled once or twice daily.
• Maximum dose / adjustments: Lowest effective dose.

Safety

• Contraindications: Acute bronchospasm primary treatment.
• Black box warning: None.
• Interactions: Strong CYP3A4 inhibitors.
• Pregnancy / lactation: Use if needed.
• High-alert: No.

Adverse effects

• Common side effects: Thrush, headache, hoarseness.
• Serious effects to report: Persistent thrush, systemic steroid effects at high doses.
• Antidote / reversal: Not applicable.

Nursing process

• Assessment before administration: Respiratory status, oral mucosa.
• Interventions during therapy: Rinse mouth after use.
• Monitor: Symptom control.
• Evaluation / expected outcome: Fewer symptoms.

Patient teaching

• Patient teaching: Daily controller; rinse after.
• Notify provider if: White patches, worsening control.
• Administration tips: Rinse mouth after.